August 31 (Thursday)

[PL01] Plenary Session 1: State of the Art in Cell Therapy

Date & Time	August 31 (Thu), 09:30-10:50	Auditorium
Chair	Jong Ho Won (Soonchunhyang University College of Medicine, Korea)
Presentations	Mesenchymal Stem Cell therapy Katarina Le Blanc (Karolinska Institutet, Sweden) Natural Killer Cell-Based Cancer Therapy Dan Kaufman (University of California San Diego, USA)

[PL02] Plenary Session 2: Alternative Donors

Date & Time	August 31 (Thu), 11:00-12:20	Auditorium
Chair	Hoon Kook (Chonnam National University Medical School, Korea)
Presentations	How to Improve the Outcome of CBT Vanderson Rocha (University of São Paulo, Brazil) Trends and future of the HSCT using mismatched donors Anna Sureda (Catalan Institute of Oncology, Spain)

[LS01] Luncheon Symposium 1 (Sanofi Aventis Korea)

Date & Time	August 31 (Thu), 12:30-13:10	Room A
Chair	Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)
Presentation	How Do I Avoid Complication of Chronic GVHD? Bipin Savani (Vanderbilt University Medical Center, USA)

[LS02] Luncheon Symposium 2 (BMS KOREA)

Date & Time	August 31 (Thu), 12:30-13:10	Room B
Chair	Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
Presentation	Oral Azacitidine Maintenance Therapy after Intensive Chemotherapy for Transplant-Ineligible AML Patients Michael Pfeilstöcker (Hanusch Hospital, Austria)

[LS03] Luncheon Symposium 3 (Handok Inc.)

Date & Time	August 31 (Thu), 12:30-13:10	Room C
Chair	Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation	Tafasitamab Efficacy and Safety in DLBCL Gilles Salles (Memorial Sloan Kettering Cancer Center, USA)

[LS04] Luncheon Symposium 4 (Gilead Science Korea Ltd.)

Date & Time	August 31 (Thu), 12:30-13:10	Room D-1
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentation	What is Missing in Hematology? Dong-Gun Lee (The Catholic University of Korea, Korea)

[LS05] Luncheon Symposium 5 (MSD KOREA): Prevention of Cytomegalovirus in HSCT Patients

Date & Time	August 31 (Thu), 12:30-13:10	Room D-2
Chair	Hee-Je Kim (The Catholic University of Korea, Korea)
Presentation	CMV Prophylaxis in Letermovir Era Jeong-Ok Lee (Seoul National University College of Medicine, Korea)

[JS01] Joint Symposium 1 (ASTCT-KSBMT): Is HSCT Still Relevant in Immunotherapy Era for Lymphoid Malignancies?

Date & Time	August 31 (Thu), 13:20-14:50	Room A
Chairs	Hee-Je Kim (The Catholic University of Korea, Korea) John F. DiPersio (Washington University in St. Louis, USA)
Presentations	Cell Therapies for Lymphoid Malignancies Hyunsoo Cho (Yonsei University College of Medicine, Korea) Pediatrics Perspective Rayne Rouce (Baylor College of Medicine, USA) Stem Cell Transplant Julie Vose (University of Nebraska Medical Center, USA)

[SS01] Scientific Session 1: Dealing with Practical Issues of Transplantation in Aplastic Anemia

Date & Time	August 31 (Thu), 13:20-14:50	Room B
Chairs	Ho Joon Im (University of Ulsan College of Medicine, Korea) Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
Presentations	Optimal Strategy of Transplantation in Fanconi Anemia Jae Wook Lee (The Catholic University of Korea, Korea) Choice of Appropriate Conditioning Regimens for Aplastic Anemia Nelli Bejanyan (Moffitt Cancer Center, USA) Mutational Landscape of Severe Aplastic Anemia and Implications for Therapy William Hogan (Mayo Clinic, USA)

[ES01] Education Session 1: Pathogenesis, Diagnosis, Treatment of Endothelial Damage Syndrome

Date & Time	August 31 (Thu), 13:20-14:50	Room C
Chairs	Young Tak Lim (Pusan National University School of Medicine, Korea) Jae-Yong Kwak (Chonbuk National University Medical School, Korea)
Presentations	Overview of the Endothelial Dysfunction after HSCT Junshik Hong (Seoul National University College of Medicine, Korea) Review of TMA Based on the Harmonized Consensus Opinion Sung Han Kang (University of Ulsan College of Medicine, Korea) Veno-Occlusive Disease / Sinusoidal Obstruction Syndrome Ka-Won Kang (Korea University College of Medicine, Korea)

[NS01] Nursing Session 1: Hematology Patients Care in the Digital Era (Panel discussion) (Kor.)

Date & Time	August 31 (Thu), 13:20-14:50	Room D
Chair	Minjin Choi (Samsung Medical Center, Korea)
Presentations	Real-world data (RWD): One step closer to the truth Seunghoon Han (The Catholic University of Korea, Korea) From RWD To Real-World-Evidence (RWE) in Hematologic Disease Sung-Soo Park (The Catholic University of Korea, Korea) Improving Diabetes Treatment Access and Outcomes Using Integrating Technology - Diabetes Mobile Apps - Kang Hee Sim (Samsung Medical Center, Korea) Introduction to Digital Therapeutics for Real-Time Symptom Monitoring and Providing Severity-Dependent Patient Advice Guiding Self Management or Medical Contact for Oncology Patients Jihyon Youn (All Round Doctors, Korea)

[JS02] Joint Symposium 2 (TSBMT-KSBMT): Experiences and Future Perspectives on Transplantation and Cellular Therapy for Multiple Myeloma

Date & Time	August 31 (Thu), 16:40-17:40	Room A
Chairs	Je-Jung Lee (Chonnam National University Medical School, Korea) Ahmet Kursad Gunes (Ankara Etlik City Hospital, Türkiye)
Presentations	Cellular Therapies in Multiple Myeloma: Revolutionizing Treatment Approaches Ahmet Kursad Gunes (Ankara Etlik City Hospital, Türkiye) Bispecific Antibodies in Multiple Myeloma Ja Min Byun (Seoul National University College of Medicine, Korea)

[SS02] Scientific Session 2: Immunotherapy for Lymphoid Malignancy in the Post-CAR T Era

Date & Time	August 31 (Thu), 16:40-18:10	Room B
Chairs	Ki-Seong Eom (The Catholic University of Korea, Korea) Ho-Jin Shin (Pusan National University School of Medicine, Korea)
Presentations	Novel Strategies to Overcome Relapsed/Refractory Multiple Myeloma Suzanne Trudel (University of Toronto, Canada) Novel Immunotherapy for Relapsed and Refractory B-Cell Lymphomas Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) Best Positioning of Immunotherapy in Adult B-Cell ALL Mark R. Litzow (Mayo Clinic, USA)

[SS03] Scientific Session 3: Transplantation Related Immunology

Date & Time	August 31 (Thu), 16:40-18:10	Room C
Chairs	Sung-Soo Yoon (Seoul National University College of Medicine, Korea) Myungshin Kim (The Catholic University of Korea, Korea)
Presentations	Immune Reconstitution after HSCT Stefan Nierkens (Princess Máxima Center for Pediatric Oncology, Netherlands) Proteomics in HSCT Sophie Paczesny (Medical University of South Carolina, USA) GVHD Immunology Geoffrey R. Hill (Fred Hutchinson Cancer Center, USA)

[ES02] Education Session 2: Conditioning Regimen in Transplant Setting

Date & Time	August 31 (Thu), 16:40-18:10	Room D
Chairs	Eun Sun Yoo (Ewha Womans University College of Medicine, Korea) Seok Lee (The Catholic University of Korea, Korea)
Presentations	Conditioning Regimens: TBI and Non-TBI Regimens Jae-Ho Yoon (The Catholic University of Korea, Korea) Dose Intensity for Conditioning in Allogeneic Hematopoietic Cell Transplantation: Reduced Intensity Conditioning Versus. Myeloablative Conditioning Yunsuk Choi (University of Ulsan College of Medicine, Korea) Novel Conditioning Regimens for Hematopoietic Cell Transplantation Sungnam Lim (Inje University College of Medicine, Korea)

September 1 (Friday)

[SS04] Scientific Session 4: Divergent Approaches to the Use of Autologous Hematopoietic Stem Cell Transplantation

Date & Time	September 1 (Fri), 09:00-10:30	Room A
Chairs	Hyeon Jin Park (National Cancer Center, Korea) Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
Presentations	NK Cells in Autologous Stem Cell Transplantation Hareth Nahi (Karolinska Institutet, Sweden) Homology Directed Repair based Gene Editing (HDR-Editing): A Precise and Versatile Method to Engineer Hematopoietic Stem Cells to Treat Rare and Common Diseases Matthew H Porteus (Stanford University, USA) Autologous Stem Cell Transplantation in Pediatric Solid Tumor: Clinical Benefit and Late Effect Ji Won Lee (Sungkyunkwan University School of Medicine, Korea)

[SS05] Scientific Session 5: GVHD in 2023: From Prediction to Prevention

Date & Time	September 1 (Fri), 09:00-10:30	Room B
Chairs	Jong Ho Won (Soonchunhyang University College of Medicine, Korea) Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
Presentations	New Insights into the Pathophysiology of GVHD Takanori Teshima (Hokkaido University, Japan) Predicting GVHD: From Biomarkers to Clinical Risk Score Margaret MacMillan (University of Minnesota, USA) Post-Transplant Cyclophosphamide as the New Standard for GVHD Prophylaxis Byung-Su Kim (The Catholic University of Korea, Korea)

[SS06] Scientific Session 6: New Insights in the Immune Effector Cell Therapies for Multiple Myeloma

Date & Time	September 1 (Fri), 09:00-10:40	Room C
Chairs	Chang-Ki Min (The Catholic University of Korea, Korea) Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
Presentations	Next Generation Immunotherapy in Multiple Myeloma Thomas Martin (UCSF Medical Center, USA) Clinical Utility of CAR T-Cells in Earlier-Lines in Multiple Myeloma Saad Z Usmani (Memorial Sloan Kettering Cancer Center, USA) Predictors of Response and Resistance of CAT-T or BsAb Therapy Yi Lin (Mayo Clinic, USA) Prognostic Values of MRD Status after CAR-T or BsAb Therapies Bruno Paiva (Clinica Universidad de Navarra, Spain)

[SS07] Scientific Session 7: Strategies for Successful Cord Blood Transplantation

Date & Time	September 1 (Fri), 09:00-10:40	Room D
Chairs	Jong Wook Lee (The Catholic University of Korea, Korea) Young-Ho Lee (Hanyang University College of Medicine, Korea)
Presentations	Recent Update of Cord Blood Transplantation in Adult Dong-Yeop Shin (Seoul National University College of Medicine, Korea) Experience of Cord Blood Transplantation in Japan Satoshi Takahashi (The University of Tokyo, Japan) Experience of Cord Blood Transplantation in USA Filippo Milano (Fred Hutchinson Cancer Center, USA) The Status of Cord Blood Banks (CBBs) for Unrelated Hematopoietic Stem Cell Transplantation (UR-HCT) & its Management of CBBs in Korea Jung Lim Lee (Daegu Fatima Hospital, Korea)

[PL03] Plenary Session 3: HSCT in Myeloid Diseases

Date & Time	September 1 (Fri), 10:50-11:30	Auditorium
Chair	Hee-Je Kim (The Catholic University of Korea, Korea)
Presentation	Biology and Strategy to Prevent and Treat Post-HSCT Relapse in Myeloid Diseases John F. DiPersio (Washington University in St. Louis, USA)

[PS] Presidential Symposium

Date & Time	September 1 (Fri), 11:30-12:10	Auditorium
Chair	Ki Woong Sung (Sungkyunkwan University School of Medicine, Korea)
Presentation	New Insights and Challenges in Managing Chronic GVHD Stephanie Lee (Fred Hutch Cancer Center, USA)

[LS06] Luncheon Symposium 6 (Kyowa Kirin Korea)

Date & Time	September 1 (Fri), 12:20-13:00	Room A
Chair	Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
Presentations	Mogamulizumab for the Treatment of MF and SS Youn H Kim (Stanford University School of Medicine, USA)

[LS07] Luncheon Symposium 7 (Astellas Phama Korea.Inc): A Paradigm Shift in the Management of Relapsed or Refractory AML with Emerging Novel Agents

Date & Time	September 1 (Fri), 12:20-13:00	Room B
Chair	June-Won Cheong (Yonsei University College of Medicine, Korea)
Presentations	Emerging Approach to Improving Treatment Outcome of FLT3 Mutated Relapsed/Refractory AML Naval Daver (MD Anderson Cancer Center, USA)

[LS08] Luncheon Symposium 8 (Janssen Korea): Multiple Myeloma

Date & Time	September 1 (Fri), 12:20-13:00	Room C
Chair	Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation	CD38 Antibodies in Multiple Myeloma: Molecular Mechanisms of Resistance Sophia Adamia (Harvard Medical School / BIDMC, USA)

[LS09] Luncheon Symposium 9 (Novartis Korea): GvHD

Date & Time	September 1 (Fri), 12:20-13:00	Room D
Chair	Hee-Je Kim (The Catholic University of Korea, Korea)
Presentation	Reaching for the Real-world Benefits in GvHD Corey Cutler (Dana-Farber / Harvard Cancer Center, USA)

[JS03] Joint Symposium 3 (EBMT-KSBMT):Recent Issues in HSCT and Cellular Therapy for ALL

Date & Time	September 1 (Fri), 13:10-14:50	Room A
Chairs	Hee-Je Kim (The Catholic University of Korea, Korea) Anna Sureda (Catalan Institute of Oncology, Spain)
Presentation	The Role of Allogeneic Stem Cell Transplantation in Philadelphia positive ALL in the Era of Targeted Therapy Sebastian Giebel (Maria Sklodowska-Curie National Research Institute of Oncology, Poland) CAR T-Cells in Pediatric Patients with B-cell Acute Lymphoblastic Leukemia Vanderson Rocha (University of São Paulo, Brazil) Collaboration for the National Clinical Trials in Relapsed Pediatric and Adolescent Acute Lymphoblastic Leukemia in Korea Hyery Kim (University of Ulsan College of Medicine, Korea) Treatment of Adult Acute Lymphoblastic Leukemia in Korea Han-Seung Park (University of Ulsan College of Medicine, Korea)

[SS08] Scientific Session 8: Bone Marrow Microenvironment in Hematologic Malignancy

Date & Time	September 1 (Fri), 13:10-14:40	Room B
Chairs	Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea) Myung Geun Shin (Chonnam National University Medical School, Korea)
Presentation	The Bone Marrow Microenvironment in Myeloid Leukemia Daniela Krause (Goethe University Frankfurt, Germany) PDE4B is a Potential Therapeutic Target to Disrupt the Interplay between Lymphomas and the Bone Marrow Microenvironment Sang-Woo Kim (Pusan National University, Korea) The Bone Marrow Microenvironment in Multiple Myeloma Yoon Seok Choi (Ajou Universitry School of Medicine, Korea)

[ES03] Education Session 3: Prevention and management of virus disease in HSCT patients

Date & Time	September 1 (Fri), 13:10-14:40	Room C
Chairs	Byung Soo Kim (Korea University College of Medicine, Korea) Seong Kyu Park (Soonchunhyang University College of Medicine, Korea)
Presentation	How Do I Prevent and Manage COVID-19 Infection after HSCT? Pyoeng Gyun Choe (Seoul National University College of Medicine, Korea) How I Prevent and Manage CMV And Herpes Infection after HSCT? Yae-Jean Kim (Sungkyunkwan University School of Medicine, Korea) How I Prevent and Manage HBV Reactivation after HSCT? Su Jong Yu (Seoul National University College of Medicine, Korea)

[DS01] Debate Session 1: Mismatched Unrelated vs. Haploidentical

Date & Time	September 1 (Fri), 13:10-14:50	Room D
Chair	Byung Sik Cho (The Catholic University of Korea, Korea)
Presentations	Mismatched Unrelated Hematopoietic Stem Cell Transplantation Sung-Hoon Jung (Chonnam National University Medical School, Korea) Haploidentical Jae-Cheol Jo (University of Ulsan College of Medicine, Korea)

[DS02] Debate Session 2: Consolidative SCT or not after CAR T-Cell in ALL

Date & Time	September 1 (Fri), 13:10-14:50	Room D
Chair	Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
Presentations	The Role Consolidative HSCT Following CAR T-cell Therapy in Children and Young Adults with B-ALL Jae won Yoo (The Catholic University of Korea, Korea) Optimizing CAR-T Therapy in Pediatrics Seung min Hahn (Yonsei University College of Medicine, Korea)

[JS04] East Asia Collaborative Session: Current Status of CAR-T Cell Therapy: Real-World Practice and Clinical Trials

Date & Time	September 1 (Fri), 16:40-18:20	Room A
Chair	Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) Takanori Teshima (Hokkaido University, Japan)
Presentations	CAR T Therapy for Hematological Diseases in Taiwan Bor-Sheng Ko (National Taiwan University Cancer Center, Taiwan) CAR T-Cell Therapy in China He Huang (The First Affiliated Hospital, Zhejiang University School of Medicine, China) Current Status and Future Directions in CAR T-Cell Therapy for Lymphoma in Korea Dok Hyun Yoon (University of Ulsan College of Medicine, Korea) Current Status and Challenges of CAR-T Therapy for Hematopoietic Malignancies Koji Kato (Kyushu University Graduate School of Medical Sciences, Japan)

[SS09] Scientific Session 9: Finding New Era of Haploidentical HSCT

Date & Time	September 1 (Fri), 16:40-18:10	Room B
Chair	Kyoo-Hyung Lee (Ewha Womans University School of Medicine, Korea, Korea) Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)
Presentations	PTCY Alone vs. PTCY+ATG Combination in Haploidentical HSCT Hee Young Ju (Sungkyunkwan University School of Medicine, Korea) Understanding How T and NK Cells Mediate the GVL Effect without GVHD in Haploidentical HSCT: Insights into Biological Mechanisms Loredana Ruggeri (University of Perugia, Italy) Regimen Intensity and the Role of Total Body Irradiation in Haploidentical HSCT Jongheon Jung (National Cancer Center, Korea)

[SS10] Scientific Session 10: Data to Clinic for Better Stem Cell Transplantation

Date & Time	September 1 (Fri), 16:40-18:10	Room C
Chairs	Seongsoo Jang (University of Ulsan College of Medicine, Korea) Hawk Kim (Gachon University College of Medicine, Korea)
Presentations	Electronic Health Record Use for Hematopoietic Cell Transplantation Research Sung Won Choi (University of Michigan, USA) Artificial Intelligence in Stem Cell Transplantation Shahrukh K. Hashmi (Sheikh Shakhbout Medical City, UAE) Recent Advances in Artificial Intelligence in Healthcare Yoonjae Choi (KAIST, Korea)

[ES04] Education Session 4: Current and Future Direction in Chronic GVHD

Date & Time	September 1 (Fri), 16:40-18:10	Room D
Chairs	Chul Won Choi (Korea University College of Medicine, Korea) Young Rok Do (Keimyung University School of Medicine, Korea)
Presentations	Clinical Diagnosis and Prophylaxis of Chronic GVHD Eun-Ji Choi (University of Ulsan College of Medicine, Korea) Novel Treatment and Sequence for Steroid-Refractory Chronic GVHD Eunyoung Lee (National Cancer Center, Korea) Multidisciplinary Care to Improve Outcome of Chronic GVHD Seo-Yeon Ahn (Chonnam National University Medical School, Korea)

September 2 (Saturday)

[JS05] Joint Symposium 5 (ISCT-KSBMT): Industry-Academia Bridging in Cellular Therapy: Synergies and Challenges

Date & Time	September 2 (Sat), 09:00-10:30	Room A
Chairs	Deog-Yeon Jo (Chungnam National University College of Medicine, Korea) Steve Oh (Independent Cell Therapy Leader, Singapore)
Presentations	Cell & Gene Therapy Market & CDMO Business in Korea Sun Jae Kwon (ENCell Co., Ltd., Korea) AAV Vectors as the Most Popular Viral Gene Delivery System Keerang Park (CdmoGen Co., Ltd., Korea) Engaging Cell & Gene Therapy Companies – A Singapore Scientist’s Experience Steve Oh (Independent Cell Therapy Leader, Singapore)

[SS11] Scientific Session 11: Pediatric Leukemia: Recent Advances in Treatments

Date & Time	September 2 (Sat), 09:00-10:30	Room B
Chairs	Chuhl Joo Lyu (Yonsei University College of Medicine, Korea) Nack-Gyun Chung (The Catholic University of Korea, Korea)
Presentations	Real World CAR-T in Pediatric Patients Theodore W. Laetsch (The Children's Hospital of Philadelphia, USA) Emerging Management Approaches for Pediatric Acute Lymphoblastic Leukemia Hiroto Inaba (St. Jude Children's Research Hospital, USA) Hematopoietic Stem Cell Transplantation for Pediatric AML Daisuke Tomizawa (National Center for Child Health and Development, Japan)

[SS12] Scientific Session 12: Optimizing HSCT Outcomes in Patients with High-Risk AML

Date & Time	September 2 (Sat), 09:00-10:30	Room C
Chairs	Je-Hwan Lee (University of Ulsan College of Medicine, Korea) June-Won Cheong (Yonsei University College of Medicine, Korea)
Presentations	The Role of MRD Monitoring and MRD-Directed Therapy in Patients with AML Jae-Sook Ahn (Chonnam National University Medical School, Korea) Venetoclax Combination Therapy as a Bridging for HSCT in Elderly or Unfit AML Maximilian Stahl (Dana-Farber Cancer Institute, USA) HSCT for Elderly Patients with AML: Geriatric Assessment and Transplant Decision Gi June Min (The Catholic University of Korea, Korea)

[JS06] Joint Symposium 6 (JSTCT-KSBMT): Recent Updates on the Management of MDS and JMML

Date & Time	September 2 (Sat), 10:40-12:20	Room A
Chairs	Hee-Je Kim (The Catholic University of Korea, Korea) Koji Kato (Kyushu University Graduate School of Medical Sciences, Japan)
Presentations	Prognostic Factors in Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Myelodysplastic Neoplasms: Retrospective Studies from a Nationwide Registry Data in Japan Hidehiro Itonaga (Nagasaki University, Japan) Hematopoietic Cell Transplantation for Pediatric Myelodysplastic Syndrome in Japan: JSTCT Pediatric MDS Working Group Study Shohei Yamamoto (Tokai University, Japan) Which Donor to Use for Patients with Myelodysplastic Syndrome? Joon Ho Moon (Kyungpook National University School of Medicine, Korea) Characteristics and Clinical Outcomes of Juvenile Myelomonocytic Leukemia in Korea Eun Sang Yi (Korea University College of Medicine, Korea)

[SS13] Scientific Session 13: Recent Advances in Cellular Immunotherapy

Date & Time	September 2 (Sat), 10:40-12:20	Room B
Chairs	Hyeon Seok Eom (National Cancer Center, Korea) Je-Jung Lee (Chonnam National University Medical School, Korea)
Presentations	Tumor Microenvironment in CAR T-Cell Therapy Saad S. Kenderian (Mayo Clinic, USA) Engineered T Cells Produced From “Alternative Cellular Sources” Hiroshih Kawamoto (Kyoto University, Japan) TCR-T Cells for Cancer Premal D. Lulla (Baylor College of Medicine, USA) Revolutionizing Solid Tumor Immunotherapy with CAR-NK Cells Mihue Jang (KIST, Korea)

[NS02] Nursing Session 2: Future Strategy (Kor.)

Date & Time	September 2 (Sat), 10:40-12:10	Room C
Chair	Jin Hee Jung (Seoul National University, Korea)
Presentations	Precision Medicine in Hematologic Disease Sheehyun Kim (Seoul National University College of Medicine, Korea) Clinical Experience of Covid-19 in Hematologic Patients Chang Kyung Kang (Seoul National University College of Medicine, Korea) Emergency Preparedness and Response in Nursing during Unpredictable Pandemic Jae Geum Ryu (Chodang University, Korea)